Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of “Global Human Drugs for Veterinary Use Market – which is forecasted from 2020 to 2027”.
The prime factor driving the growth of the global human drugs for veterinary use market is the rising trend of owning companion animals, resulting in increased spending on pet healthcare. This, in turn, will increase the demand for animal pharmaceuticals and drugs.
As per the report, the market of global human drugs for veterinary use market is expected to grow at a steady pace.
Human drugs are used to treat animals and have the same effects as they do on humans. These effects are known while they are being tested on animals for human use. Pharmaceutical firms produce more drugs for humans than for animals. In fact, there are no animal-specific drugs to treat specific infections or disorders. Furthermore, due to industry differences in sales and growth, veterinarians use extra-label human drugs to treat animals, these are some of the factors which are expected to propel the global human drugs for veterinary use market forward throughout the forecast period.
Based on medication, the global human drugs for veterinary use market offers Antibiotics, Non-steroidal anti-inflammatories, Opioid pain relievers, Chemotherapeutics and Others. The antibiotics segment is expected to grow significantly in the projected period. Antibiotic use includes therapeutic treatment, treatment of a group of animals when at least one is diagnosed with a clinical infection, and preventative treatment. It is an important tool for treating animal and human diseases, as well as protecting animal health and welfare. Also, antibiotics are the most commonly used category in the market because they are the most commonly prescribed drug by veterinarians.
Based on drug type, the global human drugs for veterinary use market provides Penicillin, Prednisone, Prednisolone, Diazepam, Prozac, and Others. Penicillin is the most commonly used drug in both humans and animals. It is commonly considered to be safe for use in dogs, cats, horses, livestock, and a variety of exotic pets. It contains the potential to disrupt the normal bacterial population in the guts of some species, particularly rodents., hence the demand for penicillin is growing.
Based on geography segmentation, the global human drugs for veterinary use market is segmented into North America, Europe, South America, the Middle East and Africa, and Asia Pacific regions. Geographically, the North America and Europe region is likely to account for a sizable market share and to experience quick expansion due to the trend of increasing companionship is growing in the United States, and consumption and sales of animal medicines are highest in the United States. Boehringer Ingelheim in Germany is regarded as one of the top five animal pharmaceutical companies in the world.
As a part of the report, the major players operating in the Human Drugs for Veterinary Use Market, that have been covered are The key players of human drugs for veterinary use market include Merck & Co, Zoetis, Boehringer Ingelheim, Elanco animal health, Vetoquinol S.A, Ceva Sante Animale, Virbac S.A.
View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/global-human-drugs-for-veterinary-use-market
This analytics report segments the Global Human Drugs for Veterinary Use Market on the following basis
- By Medication Type
- Non-steroidal anti-inflammatories
- Opioid pain relievers
- By Drug Type
- Prednisone and Prednisolone
- By Geography
- North America
- South America
- United Kingdom
- The Middle East and Africa
- Saudi Arabia
- Asia Pacific
- South Korea
- North America